Joshua Zhongbao
Corporate Officer/Principal at ASCLETIS PHARMA INC.
Network origin in Joshua Zhongbao first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joshua Zhongbao via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Medical Specialties | Chief Executive Officer Director/Board Member Director/Board Member | |
| Zhejiang University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Ascletis Pharmaceuticals Co., Ltd. | Corporate Officer/Principal Corporate Officer/Principal | ||
| Gannex Pharma Co Ltd. | Chief Executive Officer Chief Tech/Sci/R&D Officer | ||
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Biotechnology | Corporate Secretary Corporate Secretary | |
| XIN YUAN ENTERPRISES GROUP LIMITED | Marine Shipping | Corporate Secretary Corporate Secretary | |
| SUZHOU BASECARE MEDICAL CORPORATION LIMITED | Medical Specialties | Corporate Secretary Corporate Secretary | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| KIMOU ENVIRONMENTAL HOLDING LIMITED | Real Estate Development | Corporate Secretary Corporate Secretary | |
| Gannex LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| XD INC. | Packaged Software | Corporate Secretary Corporate Secretary | |
| SINIC HOLDINGS (GROUP) COMPANY LIMITED | Real Estate Development | Corporate Secretary Corporate Secretary | |
| Ascletis BioScience Co., Ltd. | Chief Executive Officer Director/Board Member | ||
| Everonc Medicines Ltd. | Director/Board Member | ||
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao. | Pharmaceuticals: Major | Chairman | |
| HUGEL, INC. | Biotechnology | Director/Board Member | |
C-Bridge Capital GP IV Ltd.
 C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Part of CBC Group Investment Management Ltd., C-Bridge Capital GP IV Ltd. provides investment services. | Financial Conglomerates | Director/Board Member | |
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Pharmaceuticals: Major | Director/Board Member | |
| Everest Medicines II BVI Ltd. | Director/Board Member | ||
| Everest Medicines II HK Ltd. | Director/Board Member | ||
Macau CPM Holdings
 Macau CPM Holdings Advertising/Marketing ServicesCommercial Services Macau CPM Holdings is an investment company, which engages in the provision of property management services. It operates through the following business segments: Parking Management, Building and Facility Management, and Security Service. The company was founded on November 1, 2017 and is headquartered in Macau. | Advertising/Marketing Services | Corporate Secretary | |
Shanghai Xingzang Technology (Group) Co., Ltd.
 Shanghai Xingzang Technology (Group) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Hujiang Education & Technology (Shanghai) Corp. Ltd. engages in the operation of an online educational platform. It operates through the following segments: Proprietary Courses Business, CCtalk Platform Business, and Others. The Proprietary courses business segment engages in the provision of online education services. The CCtalk platform business segment operates an internet platform for the facilitating the delivery of educational program and other training programs. The Others segments involves operations that may not be categorized into the main business segments. The company was founded by Cai Rui Fu in 2001 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Corporate Secretary | |
| Everonc Medicines, Inc. | Director/Board Member | ||
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Pharmaceuticals: Major | Director/Board Member | |
| Everest Medicines (Singapore) Pte Ltd. | Director/Board Member | ||
| CBC Group Co., Ltd. | Chief Executive Officer | ||
The Hong Kong Institute of Chartered Secretaries
 The Hong Kong Institute of Chartered Secretaries Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Chartered Secretaries is an independent professional body that promotes the role of its members in formulating and implementing good governance policies. The private company is based in Hong Kong, Hong Kong. It also aims to develop the profession of chartered secretary and chartered governance professional in mainland China. The institute was established in 1949 as an association of members of the Chartered Governance Institute and gained local status in 1994. It has more than 6,000 members and 3,200 students. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| EVEREST MEDICINES LIMITED | Pharmaceuticals: Major | Chairman | |
| FAR EAST HORIZON LIMITED | Finance/Rental/Leasing | Corporate Officer/Principal | |
| Standard Chartered Business Consulting Beijing Co. Ltd. | Corporate Officer/Principal | ||
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management Ltd is a private equity firm founded in 2009. The firm is headquartered in Hong Kong. | Investment Managers | Corporate Officer/Principal | |
| C-Bridge Capital Investment Management Ltd. | Chief Executive Officer | ||
| I-MAB | Pharmaceuticals: Major | Director/Board Member | |
| Nanyang Technological University | College/University | Undergraduate Degree | |
| SW Corporate Services Group Hong Kong Ltd. | Corporate Officer/Principal | ||
| YINCHENG LIFE SERVICE CO., LTD. | Real Estate Development | Corporate Secretary | |
The Chartered Governance Institute
 The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Yang Guang Xin Ye Real Property Co., Ltd. | Corporate Officer/Principal | ||
NYU Langone Medical Center
 NYU Langone Medical Center Hospital/Nursing ManagementHealth Services NYU Langone Medical Center is a premier academic medical center in the United States that is committed to excellence in patient care, medical education, and scientific research. The center is based in New York, NY, and has subsidiaries in the United States. The center offers a variety of non-degree educational programs, including the Pharmacy Technician Training Program and the PhD program at Vilcek Institute of Graduate Biomedical Sciences. NYU Langone Health's office of science and research is led by a team that is committed to supporting the excellence of their research enterprise. | Hospital/Nursing Management | Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
| CYTODYN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
| aSIA Metropolitan University | College/University | Masters Business Admin | |
| Ningbo No. 1 Hospital | Corporate Officer/Principal | ||
| Bristol-Myers Squibb, Merck & Co. | Corporate Officer/Principal | ||
| Sino-American Pharmaceutical Professionals Association | President | ||
| University of Saskatchewan | College/University | Doctorate Degree |
Statistics
International
| China | 16 |
| United States | 14 |
| Hong Kong | 8 |
| Cayman Islands | 4 |
| Canada | 3 |
Sectoral
| Health Technology | 15 |
| Consumer Services | 7 |
| Finance | 7 |
| Commercial Services | 5 |
| Transportation | 2 |
Operational
| Director/Board Member | 40 |
| Corporate Secretary | 36 |
| Corporate Officer/Principal | 33 |
| Independent Dir/Board Member | 13 |
| Undergraduate Degree | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Jiong Gu | 26 |
| Ming Fai Chung | 22 |
| Wei Fu | 21 |
| Lok Kwan Yim | 21 |
| Jinzi Wu | 20 |
| Melissa Palmer | 8 |
| Lin Hua | 7 |
| John Gargiulo | 6 |
| Judy Hejingdao Wu | 6 |
| Yan Yuemei | 6 |
| Handan He | 4 |
| Lindi Tan | 3 |
| Yizhen Wei | 3 |
| Zhengqing Li | 1 |
| Jianjiong Wang | 1 |
- Stock Market
- Insiders
- Joshua Zhongbao
- Company connections
